Literature DB >> 16766795

The absolute structural requirement for a proline in the P3'-position of Bowman-Birk protease inhibitors is surmounted in the minimized SFTI-1 scaffold.

Norelle L Daly1, Yi-Kuang Chen, Fiona M Foley, Paramjit S Bansal, Rekha Bharathi, Richard J Clark, Christian P Sommerhoff, David J Craik.   

Abstract

SFTI-1 is a small cyclic peptide from sunflower seeds that is one of the most potent trypsin inhibitors of any naturally occurring peptide and is related to the Bowman-Birk family of inhibitors (BBIs). BBIs are involved in the defense mechanisms of plants and also have potential as cancer chemopreventive agents. At only 14 amino acids in size, SFTI-1 is thought to be a highly optimized scaffold of the BBI active site region, and thus it is of interest to examine its important structural and functional features. In this study, a suite of 12 alanine mutants of SFTI-1 has been synthesized, and their structures and activities have been determined. SFTI-1 incorporates a binding loop that is clasped together with a disulfide bond and a secondary peptide loop making up the circular backbone. We show here that the secondary loop stabilizes the binding loop to the consequences of sequence variations. In particular, full-length BBIs have a conserved cis-proline that has been shown previously to be required for well defined structure and potent activity, but we show here that the SFTI-1 scaffold can accommodate mutation of this residue and still have a well defined native-like conformation and nanomolar activity in inhibiting trypsin. Among the Ala mutants, the most significant structural perturbation occurred when Asp14 was mutated, and it appears that this residue is important in stabilizing the trans peptide bond preceding Pro13 and is thus a key residue in maintaining the highly constrained structure of SFTI-1. This aspartic acid residue is thought to be involved in the cyclization mechanism associated with excision of SFTI-1 from its 58-amino acid precursor. Overall, this mutational analysis of SFTI-1 clearly defines the optimized nature of the SFTI-1 scaffold and demonstrates the importance of the secondary loop in maintaining the active conformation of the binding loop.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16766795     DOI: 10.1074/jbc.M601426200

Source DB:  PubMed          Journal:  J Biol Chem        ISSN: 0021-9258            Impact factor:   5.157


  23 in total

Review 1.  Circular proteins from plants and fungi.

Authors:  Ulf Göransson; Robert Burman; Sunithi Gunasekera; Adam A Strömstedt; K Johan Rosengren
Journal:  J Biol Chem       Date:  2012-06-14       Impact factor: 5.157

2.  Albumins and their processing machinery are hijacked for cyclic peptides in sunflower.

Authors:  Joshua S Mylne; Michelle L Colgrave; Norelle L Daly; Aurelie H Chanson; Alysha G Elliott; Emily J McCallum; Alun Jones; David J Craik
Journal:  Nat Chem Biol       Date:  2011-03-20       Impact factor: 15.040

Review 3.  Using backbone-cyclized Cys-rich polypeptides as molecular scaffolds to target protein-protein interactions.

Authors:  Dipankar Chaudhuri; Teshome Aboye; Julio A Camarero
Journal:  Biochem J       Date:  2019-01-11       Impact factor: 3.857

4.  Interleukin-10 plays a crucial role in suppression of experimental autoimmune encephalomyelitis by Bowman-Birk inhibitor.

Authors:  Hong Dai; Bogoljub Ciric; Guang-Xian Zhang; Abdolmohamad Rostami
Journal:  J Neuroimmunol       Date:  2012-02-25       Impact factor: 3.478

5.  In vivo efficacy of anuran trypsin inhibitory peptides against staphylococcal skin infection and the impact of peptide cyclization.

Authors:  U Malik; O N Silva; I C M Fensterseifer; L Y Chan; R J Clark; O L Franco; N L Daly; D J Craik
Journal:  Antimicrob Agents Chemother       Date:  2015-01-26       Impact factor: 5.191

6.  High-affinity cyclic peptide matriptase inhibitors.

Authors:  Pedro Quimbar; Uru Malik; Christian P Sommerhoff; Quentin Kaas; Lai Y Chan; Yen-Hua Huang; Maresa Grundhuber; Kerry Dunse; David J Craik; Marilyn A Anderson; Norelle L Daly
Journal:  J Biol Chem       Date:  2013-04-02       Impact factor: 5.157

7.  An engineered cyclic peptide alleviates symptoms of inflammation in a murine model of inflammatory bowel disease.

Authors:  Claudia Cobos Caceres; Paramjit S Bansal; Severine Navarro; David Wilson; Laurianne Don; Paul Giacomin; Alex Loukas; Norelle L Daly
Journal:  J Biol Chem       Date:  2017-05-04       Impact factor: 5.157

8.  Sunflower trypsin inhibitor 1 derivatives as molecular scaffolds for the development of novel peptidic radiopharmaceuticals.

Authors:  Regine García Boy; Walter Mier; Eva Maria Nothelfer; Annette Altmann; Michael Eisenhut; Harald Kolmar; Michael Tomaszowski; Susanne Krämer; Uwe Haberkorn
Journal:  Mol Imaging Biol       Date:  2009-11-24       Impact factor: 3.488

9.  Selection of peptomeric inhibitors of bovine alpha-chymotrypsin and cathepsin G based on trypsin inhibitor SFTI-1 using a combinatorial chemistry approach.

Authors:  Anna Łegowska; Dawid Debowski; Adam Lesner; Magdalena Wysocka; Krzysztof Rolka
Journal:  Mol Divers       Date:  2009-04-09       Impact factor: 2.943

10.  Semienzymatic cyclization of disulfide-rich peptides using Sortase A.

Authors:  Xinying Jia; Soohyun Kwon; Ching-I Anderson Wang; Yen-Hua Huang; Lai Y Chan; Chia Chia Tan; K Johan Rosengren; Jason P Mulvenna; Christina I Schroeder; David J Craik
Journal:  J Biol Chem       Date:  2014-01-14       Impact factor: 5.157

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.